Carboxylic Acids

<p>5-Oxo Rosuvastatin is a drug product that has been synthesized from natural ingredients. It is an analytical standard for the impurity, 5-oxo-rosuvastatin, which is a potential impurity in the API, rosuvastatin. This drug product has been custom synthesized in order to provide an Impurity Standard for HPLC. This drug product is also used as a Synthetic Reference Standard for Drug Development and Research and Development.</p>

<p>3-Isopropylisoxazole-5-carboxylic acid (3IPA) is an inhibitor of voltage-gated calcium channels. It has been shown to be effective in the treatment of neuropathic pain by reducing the excitability of neurons. 3IPA exhibits its analgesic properties through its binding to the t-type calcium channel, which is responsible for regulating the flow of calcium ions into cells. 3IPA also reduces neuronal excitability by inhibiting voltage-gated potassium channels and glutamate release. 3IPA may be a potential therapeutic agent for neuropathic pain, as it provides a novel approach to treating this type of pain.</p>

<p>Please enquire for more information about Ethyl 3-{[(1E)-(dimethylamino)methylene]amino}-5-methoxy-1-methyl-1H-indole-2-carboxylate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about tert-Butyl ((diphenylphosphoryl)methyl)sulfonylcarbamate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>N-Succinimdyl-N-methylcarbamate is a reactive, antimicrobial agent that inhibits the activity of an enzyme in the cycle of cellular respiration. It binds to the active site of the enzyme, preventing it from functioning. N-Succinimdyl-N-methylcarbamate has been shown to inhibit hepatitis by inducing apoptosis. The drug has a phase transition temperature of approximately -6°C and is stable at higher temperatures. N-Succinimdyl-N-methylcarbamate has been shown to have an inhibitory effect on cyclic peptides, including those found in bacteria such as Helicobacter pylori and Chlamydia trachomatis.</p>

<p>a functionalised glucoside</p>

<p>2,2,2-Trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide is a neuroprotective drug that belongs to the class of hydrazides. It has been shown to have neurotrophic activity in vitro and in vivo and can be used for the treatment of conditions such as diabetic neuropathy or cancer tissues. 2,2,2-Trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide also has anti-inflammatory properties and can be used for the treatment of autoimmune diseases. The drug's mechanism of action is not fully understood but is thought to involve monoamine neurotransmitters.</p>

<p>Please enquire for more information about 4-{[1-(tert-Butoxycarbonyl)azetidin-3-yl]oxy}benzoic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Native Melan-A (26-35) decapeptide derives from the melanocyte lineage-specific protein Melan-A/MART-1, which is expressed in almost 75-100% of primary and metastatic melanomas.<br>The region 26-35 of Melan-A protein acts as an antigenic peptide that is recognized by CD8+ tumor-reactive cytolytic T lymphocytes (CTLs) for designing antigen-specific cancer vaccines1. It has been shown that CD8+ Melan-A-specific CTLs isolated from melanoma patients efficiently lyse the Melan-A-expressing HLA-A*0201+ melanoma cell line. However, CTLs preferentially recognize the Melan-A (26-35) peptide as compared with the Melan-A (27-35) peptide. Moreover, the Melan-A (26-35) A27L analog (ELAGIGILTV) has a higher binding affinity to HLA-A*0201 than the native Melan-A (26-35) peptide (EAAGIGILTV), and consequently displays more potent antigenicity and immunogenicity.<br>It has been reported that the concentration of Melan-A (26-35) A27L analog required to obtain 50% of maximal antigenic activity (EC50) is 0.01nM, whereas that of the native Melan-A (26-35) peptide is 0.25nM1. Therefore, the relative activity of Melan-A (26-35) A27L analog is 25 fold higher than that of the native Melan-A (26-35) peptide.<br>Furthermore, functional competition assay has shown that the concentration of Melan-A (26-35) A27L analog required to achieve 50% inhibition (IC50) of tumor lysis is 2nM, which is 10 fold lower than that of the native Melan-A (26-35) peptide. Regarding peptide stability in human serum, the half-lifes (t1/2) of the native Melan-A (26-35) peptide and the A27L analog are quite similar (45 and 40min, respectively) as measured by HPLC-ESI-MS, but much higher than that of the Melan-A (27-35) nonapeptide (5min).</p>

<p>9,10-Anthracenediyl-bis(methylene)dimalonic acid (ADMA) is a fluorescent probe that is used to measure the levels of ADMA in cells. This compound is able to bind to cell nuclei, which can then be detected by fluorescence microscopy. ADMA has been shown to be useful as a marker for cancer and other diseases such as diabetes or Alzheimer's disease. The detection sensitivity of ADMA can be increased by combining it with heparin, which binds strongly to this molecule and increases its solubility in water. The use of ADMA as an imaging agent has been reported in several clinical studies.</p>

<p>4-Methylcyclohex-3-ene-1-carboxylic acid is an anionic compound that is used in the preparation of perfumes. This substance has been shown to have a cycloaddition reaction with nonionic detergents and isoprene, catalyzing the oxidation of terephthalic acid to ethylene. 4-Methylcyclohex-3-ene-1-carboxylic acid can also be used as a medicinal agent for aromatization or as a catalyst for the production of aldehydes.</p>

<p>3-Bromo-4-pyridinecarboxylic acid is a naphthyridine derivative that is used in drug development. It is a crystalline solid that can be dissolved in organic solvents. 3-Bromo-4-pyridinecarboxylic acid has been shown to have antiinflammatory properties and can be used as an oxidant. 3-Bromo-4-pyridinecarboxylic acid is being investigated as a receptor subtype for inflammatory diseases, and it has also been used to study the mechanism of chronic inflammatory diseases.</p>

<p>Please enquire for more information about (R)-3-Amino-butyric acid methyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Phenylphosphonic acid is an inorganic compound that belongs to the group of phosphonic acids. It is used as a model system for reactions involving zirconium oxide, pyrazole ring, and p-nitrophenyl phosphate. Phenylphosphonic acid has been shown to be able to efficiently react with metal hydroxides under acidic conditions. The rate of this reaction increases with increasing concentration of the metal hydroxide and decreasing pH. This reaction also produces picolinic acid, which can be detected by its yellow color. Phenylphosphonic acid has been shown to have covalent linkages between nitrogen atoms and phosphorus atoms. X-ray crystal structures have revealed that the molecule has a linear structure with the nitrogen atom located on one side of the molecule and the phosphorus atom on the other side. It also contains two electron pairs at its center, which are responsible for its electrochemical properties.</p>

<p>2-Methyl-4-(2-methylbenzamido)benzoic acid is a synthetic drug that has oxidizing properties. It is used as an intermediate in the synthesis of medicines, and can also be used as an intermediate in the synthesis of dyes and pesticides. The structure of this molecule consists of two methyl groups on a benzene ring with two aminobenzoic acid molecules attached to it. This molecule has hydrogen bonds with both aminobenzoic acid groups, one of which has an alkyl group attached to it. 2-Methyl-4-(2-methylbenzamido)benzoic acid crystallizes in the monoclinic system and its molecular weight is 256.24 g/mol.</p>

<p>5,6-Epoxy retinoic acid is a synthetic retinoid that has been shown to have biological properties in tissue culture and rat liver microsomes. It is an agonist of the retinoic acid receptor (RAR) and binds to DNA at the same site as all-trans retinoic acid. 5,6-Epoxyretinoic acid also has effects on gene expression in human serum and inhibits the proliferation of cancer cells by inducing apoptosis. The synthetic retinoid can be used as a novel chemotherapeutic agent for breast cancer or leukemia.</p>

<p>Please enquire for more information about tert-Butyl-n-(6-methoxy-3-pyridyl)carbamate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2-Bromoisonicotinic acid is a phenylpyridine molecule that has been shown to have inhibitory activity against the NF-κB pathway, which regulates inflammatory responses. This compound inhibits the production of TNF-α triggered by lipopolysaccharide (LPS) in vitro and in vivo. 2-Bromoisonicotinic acid may be synthesized from commercially available starting materials and can be easily scaled up for large-scale synthesis. The properties of this molecule make it an excellent candidate for further investigation as a potential therapeutic or prophylactic agent for diseases involving inflammation.</p>

<p>Please enquire for more information about 6a-Ethyl-chenodeoxycholic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about N-Nitroso-N-methyl-4-aminobutyric acid methyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>